Form 4 for VNRX VOLITIONRX LTD
Accepted 2024-09-30 00:00:00 ET · period of report 2024-09-30 · accession 0001477932-24-006042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-30 | VNRX | Rubin Ethel | Dir | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-30 | A | A | 15,000 | $0.00 | 15,000 | D | — | — | (F1) The reporting person received 15,000 restricted stock units ("RSUs") under the Issuer's 2015 Stock Incentive Plan, vesting in three equal installments of 5,000 units on each of September 30, 2025, September 30, 2026 and September 30, 2027, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested. |